HOOKIPA Pharma Inc (HOOK)
0.9302
+0.01
(+1.34%)
USD |
NASDAQ |
May 03, 16:00
0.9123
-0.02
(-1.92%)
After-Hours: 20:00
HOOKIPA Pharma Max Drawdown (5Y): 97.84% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 97.84% |
| March 31, 2024 | 97.84% |
| February 29, 2024 | 97.84% |
| January 31, 2024 | 97.84% |
| December 31, 2023 | 97.84% |
| November 30, 2023 | 97.84% |
| October 31, 2023 | 97.80% |
| September 30, 2023 | 97.02% |
| August 31, 2023 | 96.64% |
| July 31, 2023 | 96.38% |
| June 30, 2023 | 96.38% |
| May 31, 2023 | 96.38% |
| April 30, 2023 | 96.38% |
| March 31, 2023 | 96.31% |
| February 28, 2023 | 96.26% |
| January 31, 2023 | 96.26% |
| December 31, 2022 | 96.26% |
| November 30, 2022 | 94.87% |
| October 31, 2022 | 94.11% |
| September 30, 2022 | 93.54% |
| August 31, 2022 | 93.54% |
| July 31, 2022 | 93.54% |
| June 30, 2022 | 93.54% |
| May 31, 2022 | 93.54% |
| April 30, 2022 | 93.54% |
| Date | Value |
|---|---|
| March 31, 2022 | 93.54% |
| February 28, 2022 | 93.54% |
| January 31, 2022 | 93.13% |
| December 31, 2021 | 88.06% |
| November 30, 2021 | 83.50% |
| October 31, 2021 | 75.81% |
| September 30, 2021 | 69.81% |
| August 31, 2021 | 67.15% |
| July 31, 2021 | 61.92% |
| June 30, 2021 | 58.30% |
| May 31, 2021 | 58.30% |
| April 30, 2021 | 58.30% |
| March 31, 2021 | 58.30% |
| February 28, 2021 | 58.30% |
| January 31, 2021 | 58.30% |
| December 31, 2020 | 58.30% |
| November 30, 2020 | 58.30% |
| October 31, 2020 | 58.30% |
| September 30, 2020 | 58.30% |
| August 31, 2020 | 58.30% |
| July 31, 2020 | 58.30% |
| June 30, 2020 | 58.30% |
| May 31, 2020 | 58.30% |
| April 30, 2020 | 58.30% |
| March 31, 2020 | 58.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
41.34%
Minimum
May 2019
97.84%
Maximum
Nov 2023
76.80%
Average
79.65%
Median
Max Drawdown (5Y) Benchmarks
| Absci Corp | -- |
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |